Researchers have invented a new genetic test that will predict whether you will make it to your century. They have developed a computer program that will provide people with probability of reaching the age of hundred and will tell if their chances are higher or lower than average. It would allow people not sacred with centenarian gene to make changes to their lifestyle to maximize the time they have.
In a study researchers from Boston University studied the DNA of one thousand and six hundred centenarian people that include some as old as one hundred and nineteen yeas. They compared those with DNA of other people. The study highlighted one hundred and fifty hereditary changes that were more common in people who lived to a ripe old age.
These mutations could be conked out in nineteen genetic signatures, reports the journal Science. Some signatures associate with the longest survival while other signatures associate with the tardiest onset of age related conditions like dementia or cardiovascular disease. Realizing how these genes elongate life and protect against illness could lead to new drug to fight disease, explained lead researcher Dr. Paola Sebastiani.
Researchers are in process of completing the work on a computer program that can tell if someone is predispose to a long life, providing they have information on their genetic code to hand. The method is only seventy-seven percent precise. Only one in fifteen has the right combination of gene to live to hundred.
But only one in six hundred really make it. Other aspects like diet, healthcare and exercise are immensely significant. Having those genes did not mean you were invulnerable to having an accident or getting knocked down warned bioethicist Dr Muireann Quigley from Manchester University.
Their expectation has always been that they would learn much more about how to get lots of people to live to an older age in good health and noticeably delay their disability and age of onset of diseases towards the very end of their lives, however long that would be, explained Dr Tom Perls, professor of medicine from Boston University.